<SEC-DOCUMENT>9999999997-21-003338-index.html : 20210809
<SEC-HEADER>9999999997-21-003338.hdr.sgml : 20210809
<ACCEPTANCE-DATETIME>20210610131453
ACCESSION NUMBER:		9999999997-21-003338
CONFORMED SUBMISSION TYPE:	SEC STAFF LETTER
CATEGORY:             	REDACTED EXHIBIT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210607
ACTION DATE:               	20210607
RECEIVED DATE:           	20210610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Unicycive Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001766140
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813638692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SEC STAFF LETTER

	BUSINESS ADDRESS:	
		STREET 1:		5150 EL CAMINO REAL, SUITE A-32
		CITY:			LOS ALTOS
		STATE:			CA
		ZIP:			94022
		BUSINESS PHONE:		650-384-0642

	MAIL ADDRESS:	
		STREET 1:		5150 EL CAMINO REAL, SUITE A-32
		CITY:			LOS ALTOS
		STATE:			CA
		ZIP:			94022
</SEC-HEADER>
<DOCUMENT>
<TYPE>REDACTED EXHIBIT
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
Document 1 - file: filename1.pdf

</DOCUMENT>
</SEC-DOCUMENT>